Stigningerne i BMD fra baseline for lumbal columna var ens i Preotact - og kombinationsbehandlingsgruppen (6, 3 og 6, 1%), men var lidt mindre i alendronat- gruppen (4, 6%).
The increases in lumbar spine BMD above baseline were similar in the Preotact and combination-therapy groups (6.3 and 6.1%, respectively), but were somewhat smaller in the alendronate group (4.6%).